| Literature DB >> 31396529 |
Abstract
BACKGROUND AND OBJECTIVES: Environmental pollution with the different Aluminum (Al) containing compounds has been increased. Liver and kidney are two vital organs targeted by Al accumulation. The aim of this study was to assess the possible protective and curative effects of Lepidium sativum Linn (LS) against Al-induced impairment of liver and kidney in albino rat and to explore the mechanism behind this effect.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31396529 PMCID: PMC6668553 DOI: 10.1155/2019/4516730
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Comparison of body weights in different studied groups.
| Parameters | Control | LS-treated | AlCl3-treated | AlCl3 then LS | AlCl3 plus LS |
|---|---|---|---|---|---|
| Initial body weight (g) | 224.78±17.33 | 212.56±14.78 | 219.67±17.1 | 228.56±26.8 | 212.56±14.78 |
|
| |||||
| P#=0.173 | P#=0.565 | P#=0.670 | P#=0.173 | ||
|
| |||||
| Final body weight (g) | 316.78±13.45 | 326.11±29.15 | 227.56±17.5 | 309.44±40.1 | 251.56±10.7 |
|
| |||||
| Significance | P#=0.429 | P#<0.001 | P#=0.533 | P#=0.001 | |
|
| |||||
| Weight gain | 92.00±18.61 | 110.22±33.41 | 7.67±2.87 | 69.78±29.6 | 39.00±14.07 |
|
| |||||
| Significance | P#=0.094 | P#<0.001 | P#=0.043 | P#<0.001 | |
|
| |||||
| Percentage changes in body weight (%) | 41.56±10.88 | 52.29±17.46 | 3.51±1.40 | 30.69±13.23 | 18.72±7.81 |
|
| |||||
| Significance | P#=0.055 | P#<0.001 | P#=0.052 | P#<0.001 | |
Data are expressed as mean±standard deviation. Comparison was made using One Way ANOVA test (LSD). P#: p value of comparison versus control; P##: p value of comparison versus AlCl3 group; P###: p value of comparison versus AlCl3 then LS group.
Comparison of lipid profiles in different studied groups.
| Parameters | Control | LS-treated | AlCl3-treated | AlCl3 then LS | AlCl3 plus LS |
|---|---|---|---|---|---|
| Cholesterol (mg/100ml) | 80.51±9.52 | 73.24±3.99 | 106.03±12.75 | 88.33±3.92 | 86.24±6.74 |
|
| |||||
| Significance | P#=0.104 | P#<0.001 | P#=0.082 | P#=0.056 | |
|
| |||||
| Triglyceride | 66.84±8.47 | 58.01±13.22 | 99.21±21.21 | 71.37±10.34 | 81.24±10.86 |
|
| |||||
| Significance | P#=0.233 | P#<0.001 | P#=0.537 | P#=0.197 | |
|
| |||||
| LDL-C | 17.17±3.02 | 14.91±1.46 | 21.04±2.90 | 19.03±1.46 | 18.19±1.28 |
|
| |||||
| Significance | P#=0.060 | P#=0.002 | P#=0.119 | P#=0.388 | |
Data are expressed as mean +/- standard deviation. Comparison was made using One Way ANOVA test (LSD). P#: p value of comparison versus control; P##: p value of comparison versus AlCl3 group; P###: p value of comparison versus AlCl3 then LS group.
Comparison of oxidative stress markers in the serum of different studied groups.
| Parameters | Control | LS-treated | AlCl3-treated | AlCl3 then LS | AlCl3 plus LS |
|---|---|---|---|---|---|
| FRAP ( | 82.20±13.33 | 150.80±15.99 | 45.40±5.68 | 65.20±9.88 | 67.80±7.79 |
|
| |||||
| Significance | P#<0.001 | P#<0.001 | P#=0.026 | P#=0.055 | |
|
| |||||
| Catalase ( | 97.60±6.11 | 99.80±3.11 | 28.60±9.45 | 57.40±10.74 | 83.00±14.78 |
|
| |||||
| Significance | P#=0.724 | P#<0.001 | P#<0.001 | P#=0.027 | |
|
| |||||
| Reduced glutathione (nmol/L) | 2.81±1.09 | 6.47±1.51 | 0.55±0.25 | 1.00±0.27 | 2.29±0.79 |
|
| |||||
| Significance | P#<0.001 | P#<0.001 | P#=0.005 | P#=0.379 | |
Data are expressed as mean +/- standard deviation. Comparison was made using One Way ANOVA test (LSD). P#: p value of comparison versus control; P##: p value of comparison versus AlCl3 group; P###: p value of comparison versus AlCl3 then LS group.
Comparison of liver functions in the serum of different studied groups.
| Parameters | Control | LS-treated | AlCl3-treated | AlCl3 then LS | AlCl3 plus LS |
|---|---|---|---|---|---|
| AST (U/L) | 105.82±11.02 | 104.36±25.41 | 154.43±22.26 | 131.63±26.15 | 133.25±7.12 |
|
| |||||
| Significance | P#=0.871 | P#=0.001 | P#<0.006 | P#=0.004 | |
|
| |||||
| ALT (U/L) | 61.41±5.50 | 55.17±7.79 | 101.12±6.64 | 78.93±9.60 | 84.19±5.91 |
|
| |||||
| Significance | P#=0.060 | P#<0.001 | P#<0.001 | P#<0.001 | |
|
| |||||
| ALP (U/L) | 193.00±22.98 | 183.10±11.97 | 92.50±14.21 | 140.70±15.84 | 138.00±19.11 |
|
| |||||
| Significance | P#=0.206 | P#<0.001 | P#<0.001 | P#<0.001 | |
|
| |||||
| Total proteins (g/L) | 5.90±0.31 | 5.80±0.30 | 5.31±0.18 | 5.62±0.32 | 5.68±0.19 |
|
| |||||
| Significance | P#=0.41 | P#<0.001 | P#=0.03 | P#=0.072 | |
|
| |||||
| Albumin (g/L) | 3.10±0.26 | 3.12±0.22 | 2.80±0.12 | 3.02±0.15 | 2.96±0.13 |
|
| |||||
| Significance | P#=0.798 | P#<0.001 | P#=0.332 | P#=0.082 | |
|
| |||||
| Total bilirubin (U/L) | 0.057±0.009 | 0.049±0.007 | 0.090±0.015 | 0.064±0.022 | 0.073±0.013 |
|
| |||||
| Significance | P#=0.25 | P#<0.001 | P#=0.29 | P#=0.015 | |
Data are expressed as mean +/- standard deviation. Comparison was made using One Way ANOVA test (LSD). P#: p value of comparison versus control; P##: p value of comparison versus AlCl3 group; P###: p value of comparison versus AlCl3 then LS group.
Comparison of kidney function tests in the serum of different studied groups.
| Parameters | Control | LS-treated | AlCl3-treated | AlCl3 then LS | AlCl3 plus LS |
|---|---|---|---|---|---|
| Creatinine (mmol/L) | 0.30±0.02 | 0.29±0.04 | 0.45±0.11 | 0.31±0.02 | 0.33±0.05 |
|
| |||||
| Significance | P#=0.869 | P#<0.001 | P#=0.681 | P#=0.206 | |
|
| |||||
| Urea (mmol/L) | 36.21±2.57 | 36.00±4.62 | 52.23±4.76 | 44.06±6.43 | 48.46±8.17 |
|
| |||||
| Significance | P#=0.944 | P#<0.001 | P#=0.014 | P#<0.001 | |
Data are expressed as mean +/- standard deviation. Comparison was made using One Way ANOVA test (LSD). P#: p value of comparison versus control; P##: p value of comparison versus AlCl3 group; P###: p value of comparison versus AlCl3 then LS group.
Figure 1Sections of kidney of control rats (a) and rats receiving LS show intact renal cortex with intact renal corpuscle (arrows) and renal tubules. Renal cortex of rats receiving AlCl3 (b-d) showing shrunken renal corpuscles (arrows) with marked hypocellularity and atrophied glomeruli. Renal tubules showed dilated lumina with hyaline casts (bifid arrows) and in some of them appear completely distorted (dotted arrows). Renal cortex of rats receiving AlCl3 then LS (e) showing intact renal corpuscles with preserved cellularity (arrow) and intact renal tubules apart from few with dilated lumina and hyaline casts (thin arrows). Renal cortex of rats receiving AlCl3 plus LS (f) showing intact structure of renal cortex (H&E X 400, Bar=100). LS: Lepidium sativum.
Figure 2Sections in liver of control (a) and rats receiving LS (b) show intact liver apart from some dilated blood sinusoids (arrow). Liver of rats receiving AlCl3 (c, d) showing massive focal hepatic necrosis with shrunken hepatocytes (bifid arrows). Damaged sinusoids with extravasation of blood cells (stars) and perivascular cell necrosis and inflammatory cells (white arrow). Liver of rats receiving AlCl3 then LS (e) showing intact structure apart from some dilated sinusoids (arrows) associated with few inflammatory cells (white arrow) while livers of rat receiving AlCl3 plus LS (f) appear intact (H&E X 400, Bar=100). LS: Lepidium sativum.